Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659
Authors:
- 20 February 2025
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (3) , e31
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Case report: First Chinese patient with family partial lipodystrophy type 6 due to novel compound heterozygous mutations in the LIPE geneFrontiers in Genetics, 2024
- Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial LipodystrophyDiabetes Care, 2024
- Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysisBMJ, 2024
- A Visual Diagnosis: LipodystrophyJCEM Case Reports, 2023
- Familial partial lipodystrophy syndromesLa Presse Médicale, 2021